Enhancing drug bioavailability: strategies from Ardena’s experts
Ardena’s Drug Product team, led by Vincent Levet (Director, Formulation Development and Production) and Timothy Pas (Group Leader, Formulation Development and Production), has recently published a comprehensive article in Drug Development & Delivery. This technical piece focuses on innovative strategies to tackle solubility and bioavailability challenges in poorly soluble drugs—key hurdles in drug development.
Highlighting advanced techniques like Amorphous Solid Dispersions (ASDs), Lipid-Based Formulations, Nanosuspensions, and Cyclodextrin Complexes, the article delves into how these approaches can optimize drug delivery, enhance therapeutic outcomes, and ultimately shorten the time-to-market. By providing in-depth insights into each formulation strategy, the team showcases how these innovations not only address solubility issues but also offer practical solutions for improving overall drug performance.
To explore more about these cutting-edge techniques and their potential impact on the pharmaceutical industry, read the full article here. A huge congratulation to the Ardena team for their innovative contribution to drug development!
Find more news here.